These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9482474)

  • 1. Effect of amiodarone on mortality.
    Landray MJ; Kendall MJ
    Lancet; 1998 Feb; 351(9101):523. PubMed ID: 9482474
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers and amiodarone for the primary prevention of sudden cardiac death.
    Frankenberger O; Steinberg JS
    Curr Cardiol Rep; 1999 Nov; 1(4):274-81. PubMed ID: 10980854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death due to cardiac arrhythmias.
    Huikuri HV; Castellanos A; Myerburg RJ
    N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-threatening arrhythmias and therapy.
    Myerburg RJ
    Resuscitation; 2000 Aug; 45(3):S1-2. PubMed ID: 10959026
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
    Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.
    Anderson JL
    Control Clin Trials; 1996 Jun; 17(3 Suppl):17S-27S. PubMed ID: 8877264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K; Nishii N; Ohe T
    Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death and the potential role of beta adrenoceptor-blocking drugs.
    Jolobe OM
    Postgrad Med J; 1994 Jul; 70(825):521-2. PubMed ID: 7937438
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ventricular anti-arrhythmic treatments during postinfarction].
    Frank R; Tonet J; Lascault G; Fontaine G
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1725-9. PubMed ID: 1363903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone for the Prevention of Sudden Cardiac Death.
    Saguil A
    Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden cardiac death and the role of medical therapy.
    Arshad A; Mandava A; Kamath G; Musat D
    Prog Cardiovasc Dis; 2008; 50(6):420-38. PubMed ID: 18474285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
    Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
    Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
    Camm AJ; Yap YG
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):99-106. PubMed ID: 11452341
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
    Melacini P; Maron BJ; Bobbo F; Basso C; Tokajuk B; Zucchetto M; Thiene G; Iliceto S
    Heart; 2007 Jun; 93(6):708-10. PubMed ID: 17502652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
    Droogan C; Patel C; Yan GX; Kowey PR
    Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
    Hagens VE; Rienstra M; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC
    Am J Cardiol; 2006 Oct; 98(7):929-32. PubMed ID: 16996876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.